high-output heart failure

High-output heart failure results from conditions that decrease systemic vascular resistance or increase metabolic demand, causing a compensatory increase in cardiac output that eventually cannot keep pace with the body's needs. The underlying mechanism often involves peripheral vasodilation or hypermetabolism, which reduces effective arterial blood volume and activates neurohormonal compensatory systems (renin-angiotensin-aldosterone system, sympathetic nervous system), leading to fluid retention and eventual cardiac decompensation.

Key etiologies (mnemonic: 'AT BEEP-P'): Anemia (reduced O2-carrying capacity increases compensatory cardiac output), Thyrotoxicosis (increased metabolic rate and heart rate), Beriberi (thiamine deficiency causing peripheral vasodilation and impaired oxidative metabolism), AV fistulas/shunts (blood bypasses capillary beds, reducing systemic vascular resistance), Paget disease of bone (increased vascularity and shunting in bone), and Pregnancy (increased blood volume and metabolic demand).

Pathophysiologically, chronically elevated cardiac output leads to cardiac remodeling, dilation, and eventually systolic dysfunction, converting the physiology to a mixed or classic low-output failure pattern over time. Clinically, patients present with warm extremities, bounding pulses, wide pulse pressure, and signs of volume overload (edema, pulmonary congestion) despite normal or increased ejection fraction and cardiac output—contrasting with cold, poorly perfused extremities typical of low-output failure.

Diagnosis relies on identifying the underlying cause (e.g., CBC for anemia, TSH for thyroid disease, thiamine levels) alongside echocardiography showing preserved or increased ejection fraction with elevated cardiac output on right heart catheterization. Treatment focuses on correcting the underlying condition (e.g., blood transfusion, thyroid management, thiamine repletion, fistula closure) in addition to standard heart failure management (diuretics, afterload reduction) if needed.

This concept is high-yield for USMLE Step 1 and Step 2, often tested via vignettes describing a patient with heart failure symptoms plus an underlying hypermetabolic or vasodilatory condition, requiring the examinee to recognize the atypical mechanism of heart failure.